"Designing Growth Strategies is in our DNA"

U.S. Autoinjectors Market Size, Share & Industry Analysis, By Type (Disposable and Reusable), By Application (Autoimmune Disorders, Diabetes, Emergency Care, and Others), By Route of Administration (Intramuscular and Subcutaneous), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Others), and Country Forecast, 2024-2032

Last Updated: November 17, 2025 | Format: PDF | Report ID: FBI108967

 

We will customize the report to meet your research goals, helping you gain a competitive edge, and make informed decisions.

  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
    4. Market Trends
  4. Key Insights
    1. Prevalence of Chronic Diseases, 2023
    2. Recent Product Launches, By Key Players
    3. Key Industry Developments (Mergers, Acquisitions, Partnerships, etc.)
    4. Impact of COVID-19 on the Market
  5. U.S. Autoinjectors Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Type
      1. Disposable
      2. Reusable
    2. Market Analysis, Insights and Forecast – By Application
      1. Autoimmune Disorders
      2. Diabetes
      3. Emergency Care
      4. Others
    3. Market Analysis, Insights and Forecast – By Route of Administration
      1. Intramuscular
      2. Subcutaneous
    4. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
  6. Competitive Analysis
    1. U.S. Market Share Analysis (2023)
    2. Company Profiles
      1. Viatris Inc.
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      2. Teva Pharmaceuticals, Inc.
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      3. Ypsomed AG
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      4. Becton Dickinson and Company
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      5. Halozyme, Inc.
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      6. AstraZeneca
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      7. Bristol-Myers Squibb
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      8. Phillips-Medisize
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      9. Xeris Pharmaceuticals, Inc.
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
    4. Market Trends
  4. Key Insights
    1. Prevalence of Chronic Diseases, 2023
    2. Recent Product Launches, By Key Players
    3. Key Industry Developments (Mergers, Acquisitions, Partnerships, etc.)
    4. Impact of COVID-19 on the Market
  5. U.S. Autoinjectors Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Type
      1. Disposable
      2. Reusable
    2. Market Analysis, Insights and Forecast – By Application
      1. Autoimmune Disorders
      2. Diabetes
      3. Emergency Care
      4. Others
    3. Market Analysis, Insights and Forecast – By Route of Administration
      1. Intramuscular
      2. Subcutaneous
    4. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
  6. Competitive Analysis
    1. U.S. Market Share Analysis (2023)
    2. Company Profiles
      1. Viatris Inc.
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      2. Teva Pharmaceuticals, Inc.
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      3. Ypsomed AG
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      4. Becton Dickinson and Company
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      5. Halozyme, Inc.
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      6. AstraZeneca
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      7. Bristol-Myers Squibb
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      8. Phillips-Medisize
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      9. Xeris Pharmaceuticals, Inc.
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
Read Less

Figure 1: U.S. Autoinjectors Market Revenue Breakdown (USD billion, %) by Type, 2023 & 2032

Figure 2: U.S. Autoinjectors Market Value Share (%), by Type, 2023 & 2032

Figure 3: U.S. Autoinjectors Market Value Share (%), by Application, 2023 & 2032

Figure 4: U.S. Autoinjectors Market Value Share (%), by Route of Administration, 2023 & 2032

Figure 5: U.S. Autoinjectors Market Value Share (%), by Distribution Channel, 2023 & 2032

Figure 6: U.S. Autoinjectors Market Share (%), By Company, 2023

Table 1: U.S. Autoinjectors Market Revenue (USD billion) Forecast, by Type, 2019–2032

Table 2: U.S. Autoinjectors Market Revenue (USD billion) Forecast, by Application, 2019–2032

Table 3: U.S. Autoinjectors Market Revenue (USD billion) Forecast, by Route of Administration, 2019–2032

Table 4: U.S. Autoinjectors Market Revenue (USD billion) Forecast, by Distribution Channel, 2019–2032

U.S. Autoinjectors Market
  • 2019-2032
  • 2023
  • 2019-2022
  • 80
Download Free Sample

    man icon
    Mail icon
    Captcha refresh
Growth Advisory Services
    How can we help you uncover new opportunities and scale faster?
Clients
3M
Toshiba
Fresenius
Johnson
Siemens
Abbot
Allergan
American Medical Association
Becton, Dickinson and Company
Bristol-Myers Squibb Company
Henry Schein
Mckesson
Mindray
National Institutes of Health (NIH)
Nihon Kohden
Olympus
Quest Diagnostics
Sanofi
Smith & Nephew
Straumann

Related Reports